Vivos Therapeutics Inc
(VVOS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,703 | -23,845 | -17,756 | -12,322 | -5,331 |
| Depreciation Amortization | 175 | 669 | 500 | 324 | 41 |
| Accounts receivable | 136 | 746 | 337 | 411 | 201 |
| Accounts payable and accrued liabilities | 84 | 491 | -276 | 331 | -42 |
| Other Working Capital | 233 | 1,711 | -175 | 859 | -358 |
| Other Operating Activity | -2,464 | 641 | 783 | -348 | -593 |
| Operating Cash Flow | $-3,539 | $-19,587 | $-16,587 | $-10,745 | $-6,082 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -239 | -924 | -724 | -624 | -120 |
| Other Investing Activity | -50 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-289 | $-924 | $-724 | $-624 | $-120 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,000 | N/A | N/A | 0 | N/A |
| Other Financing Activity | -645 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $7,355 | $N/A | $N/A | $0 | $N/A |
| Beginning Cash Position | 3,519 | 24,030 | 24,030 | 24,030 | 24,030 |
| End Cash Position | 7,046 | 3,519 | 6,719 | 12,661 | 17,828 |
| Net Cash Flow | $3,527 | $-20,511 | $-17,311 | $-11,369 | $-6,202 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,539 | -19,587 | -16,587 | -10,745 | -6,082 |
| Capital Expenditure | -239 | -924 | -724 | -624 | -120 |
| Free Cash Flow | -3,778 | -20,511 | -17,311 | -11,369 | -6,202 |